184 related articles for article (PubMed ID: 22360401)
41. NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance.
Martner A; Rydström A; Riise RE; Aurelius J; Brune M; Foà R; Hellstrand K; Thorén FB
Oncotarget; 2015 Dec; 6(40):42569-74. PubMed ID: 26544512
[TBL] [Abstract][Full Text] [Related]
42. Active but not inactive granulomatosis with polyangiitis is associated with decreased and phenotypically and functionally altered CD56(dim) natural killer cells.
Merkt W; Claus M; Blank N; Hundemer M; Cerwenka A; Lorenz HM; Watzl C
Arthritis Res Ther; 2016 Sep; 18(1):204. PubMed ID: 27624647
[TBL] [Abstract][Full Text] [Related]
43. Up-regulation of NKG2A inhibitory receptor on circulating NK cells contributes to transfusion-induced immunodepression in patients with β-thalassemia major.
Zou Y; Song ZX; Lu Y; Liang XL; Yuan Q; Liao SH; Bao JJ
J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):509-513. PubMed ID: 27465324
[TBL] [Abstract][Full Text] [Related]
44. Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells.
Vacca P; Cantoni C; Prato C; Fulcheri E; Moretta A; Moretta L; Mingari MC
Int Immunol; 2008 Nov; 20(11):1395-405. PubMed ID: 18815119
[TBL] [Abstract][Full Text] [Related]
45. NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation.
Vacca P; Martini S; Garelli V; Passalacqua G; Moretta L; Mingari MC
Eur J Immunol; 2013 Feb; 43(2):550-61. PubMed ID: 23192659
[TBL] [Abstract][Full Text] [Related]
46. Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.
Nielsen N; Ødum N; Ursø B; Lanier LL; Spee P
PLoS One; 2012; 7(2):e31959. PubMed ID: 22384114
[TBL] [Abstract][Full Text] [Related]
47. Chronic HCV infection affects the NK cell phenotype in the blood more than in the liver.
Cosgrove C; Berger CT; Kroy DC; Cheney PC; Ghebremichael M; Aneja J; Tomlinson M; Kim AY; Lauer GM; Alter G
PLoS One; 2014; 9(8):e105950. PubMed ID: 25148254
[TBL] [Abstract][Full Text] [Related]
48. Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation.
Tanimine N; Tanaka Y; Abe T; Piao J; Chayama K; Ohdan H
Transplantation; 2016 Feb; 100(2):355-64. PubMed ID: 26714120
[TBL] [Abstract][Full Text] [Related]
49. Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity.
Jacobson A; Bell F; Lejarcegui N; Mitchell C; Frenkel L; Horton H
PLoS One; 2013; 8(6):e67700. PubMed ID: 23805324
[TBL] [Abstract][Full Text] [Related]
50. Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin.
Jarahian M; Fiedler M; Cohnen A; Djandji D; Hämmerling GJ; Gati C; Cerwenka A; Turner PC; Moyer RW; Watzl C; Hengel H; Momburg F
PLoS Pathog; 2011 Aug; 7(8):e1002195. PubMed ID: 21901096
[TBL] [Abstract][Full Text] [Related]
51. Persistence of pathological distribution of NK cells in HIV-infected patients with prolonged use of HAART and a sustained immune response.
Frias M; Rivero-Juarez A; Gordon A; Camacho A; Cantisan S; Cuenca-Lopez F; Torre-Cisneros J; Peña J; Rivero A
PLoS One; 2015; 10(3):e0121019. PubMed ID: 25811634
[TBL] [Abstract][Full Text] [Related]
52. Understanding the Synergy of NKp46 and Co-Activating Signals in Various NK Cell Subpopulations: Paving the Way for More Successful NK-Cell-Based Immunotherapy.
Zamai L; Del Zotto G; Buccella F; Gabrielli S; Canonico B; Artico M; Ortolani C; Papa S
Cells; 2020 Mar; 9(3):. PubMed ID: 32204481
[TBL] [Abstract][Full Text] [Related]
53. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.
Krämer B; Körner C; Kebschull M; Glässner A; Eisenhardt M; Nischalke HD; Alexander M; Sauerbruch T; Spengler U; Nattermann J
Hepatology; 2012 Oct; 56(4):1201-13. PubMed ID: 22532190
[TBL] [Abstract][Full Text] [Related]
54. Successfully treated HIV-infected patients have differential expression of NK cell receptors (NKp46 and NKp30) according to AIDS status at presentation.
Bisio F; Bozzano F; Marras F; Di Biagio A; Moretta L; De Maria A
Immunol Lett; 2013 Apr; 152(1):16-24. PubMed ID: 23538009
[TBL] [Abstract][Full Text] [Related]
55. In silico modeling identifies CD45 as a regulator of IL-2 synergy in the NKG2D-mediated activation of immature human NK cells.
Mukherjee S; Jensen H; Stewart W; Stewart D; Ray WC; Chen SY; Nolan GP; Lanier LL; Das J
Sci Signal; 2017 Jun; 10(485):. PubMed ID: 28655861
[TBL] [Abstract][Full Text] [Related]
56. NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species.
Romero AI; Thorén FB; Brune M; Hellstrand K
Br J Haematol; 2006 Jan; 132(1):91-8. PubMed ID: 16371024
[TBL] [Abstract][Full Text] [Related]
57. Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Laroni A; Armentani E; Kerlero de Rosbo N; Ivaldi F; Marcenaro E; Sivori S; Gandhi R; Weiner HL; Moretta A; Mancardi GL; Uccelli A
J Autoimmun; 2016 Aug; 72():8-18. PubMed ID: 27157273
[TBL] [Abstract][Full Text] [Related]
58. CD16 cross-linking induces increased expression of CD56 and production of IL-12 in peripheral NK cells.
Márquez ME; Millet C; Stekman H; Conesa A; Deglesne PA; Toro F; Sanctis JD; Blanca I
Cell Immunol; 2010; 264(1):86-92. PubMed ID: 20553754
[TBL] [Abstract][Full Text] [Related]
59. Identification of human NK cells that are deficient for signaling adaptor FcRγ and specialized for antibody-dependent immune functions.
Hwang I; Zhang T; Scott JM; Kim AR; Lee T; Kakarla T; Kim A; Sunwoo JB; Kim S
Int Immunol; 2012 Dec; 24(12):793-802. PubMed ID: 22962434
[TBL] [Abstract][Full Text] [Related]
60. Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomas.
Uemura Y; Isobe Y; Uchida A; Asano J; Nishio Y; Sakai H; Hoshikawa M; Takagi M; Nakamura N; Miura I
Cancer Sci; 2018 Apr; 109(4):1254-1262. PubMed ID: 29363227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
